New Lung Cancer Study Findings Reported from Department of Anesthesiology (Effect of Sevoflurane Combined With Ulinastatin On Cell Proliferation and Migration In Lung Adenocarcinoma).

A new study from the Department of Anesthesiology in Hebei, China, explores the effect of combining sevoflurane and ulinastatin on the proliferation and migration of lung adenocarcinoma cells. The researchers found that the combination treatment significantly inhibited cell proliferation and migration in a dose-dependent manner. They also observed a decrease in the expression of proteins associated with proliferation and migration. The study suggests that sevoflurane combined with ulinastatin may have potential as a treatment for lung adenocarcinoma. [Extracted from the article]